As a prerequisite for further development of optimized UniCAR and TM combinations, we investigated functionality of the recombinant target modules in comparative binding studies and cell killing experiments with ErbB2-positive cancer cells of different solid tumor origins and NK cells carrying a first- or second-generation UniCAR. The gene discussed is ERBB2; the disease is cancer.